Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Infusion Therapy Patterns by Treatment Site Studied

J Med Econ; ePub 2017 Sep 25; Hopson, et al

Older patients who received infusion therapy as hospital outpatients experienced different patterns of treatment than those treated in physician offices, but quality of care was similar, according to a recent retrospective analysis. Participants initiated infusion therapy between 2008 and 2012 for early stage breast cancer; metastatic breast, lung, or colorectal cancer; or non-Hodgkin's lymphoma or chronic lymphocytic leukemia. Investigators looked at first-line treatment and end-of-life quality differences. Among the results:

  • Patients in the hospital outpatient setting had shorter treatment duration and fewer infusions for some regimens.
  • Quality care was similar across all sites.
  • Costs were 15% higher in patients treated in the hospital outpatient setting, compared with those seen in the physician office setting (nearly $56,000 vs ~$48,500).


Hopson S, Casebeer A, Stemkowski S, et al. Does site-of-care for oncology infusion therapy influence treatment patterns, cost and quality in the United States? [Published online ahead of print September 25, 2017]. J Med Econ. doi:10.1080/13696998.2017.1384736.

This Week's Must Reads

Six factors predict urothelial cancer response, Pond GR et al. GU Cancers Symposium Abstract 413

Combo bests single therapy in metastatic RCC, Motzer RJ et al. GU Cancers Symposium Abstract 578

Chemo is best course in resected urothelial disease, Birtle A et al. Genitourinary Cancers Symposium. Abstract 407.

Selecting chemoradiation in bladder cancer, Coen, J. et al, 2018 Genitourinary Cancers Symposium, Abstract 408.

When to choose surgery or surveillance in RCC, Hakimi A et al. J Urol. 2018 Feb 26 doi: 10.1016/j.juro.2018.02.3087.

Must Reads in Practice Management

Oncologists can learn a lot from Twitter about lung cancer patients, Sutton J. et al., J Am Coll Radiol. 2018 Jan. doi: 10.1016/j.jacr.2017.09.043.

Financial transparency by oncology clinical pathway vendors, Daly, B et al. JAMA Oncol. 2018;4(2):255-257 doi:10.1001/jamaoncol.2017.4473

Support for gender equity led to more women in academic roles, Devine et al. J Exp Soc Psychol. [in press]

Insurance against cyberhacks of medical records, Beazley breach insights - January 2018

In-office chemo costs less, Winn A et al., JAMA Oncol. 2018 Feb 22. doi: 10.1001/jamaoncol.2017.5544.